Sponsors

Referrals from primary care to nephrology: potential impact of NICE guidelines

The early stages of chronic kidney disease are usually asymptomatic, with diagnosis only achieved following blood or urine tests undertaken for another reason. Now, National Institute for Health and Care Excellence guidance is highlighting the value of these simple tests, which have been the focus of a recently published study.

PIP CKD ARTICLE web text (pp 37-38)

A simple blood and urine test can identify those most at risk of severe complications of chronic kidney disease. However, despite being recommended by the National Institute for Health and Care Excellence (NICE) in 2021, many patients and GPs remain unaware of the test’s life-saving potential.           New research, led by the University of Glasgow and published in the British Journal of General Practice, assessed patient data from across the UK and found that not enough people with chronic kidney disease were routinely being given this recommended test. The study results have prompted renewed calls from kidney specialists to encourage more patients to be given access to this test.1

Chronic kidney disease

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024